This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The objective of this project, which is part of a multicenter trial, is to investigate whether low dose inhaled nitric oxide (iNO) will decrease the risk of chronic lung disease in premature infants. The intervention is expected to increase survival without chronic lung disease (oxygen dependence at 36 weeks post-menstrual age) from 50 to 62 percent. Infants are eligible if they are less than 32 weeks gestational age, 500 to 1250 g birth weight, 7 to 21 days old, and require mechanical ventilation. Subjects are randomly assigned to receive iNO (initial dose 20 ppm) or placebo. The study gas is weaned over a three week period. Safety is evaluated by monitoring clinical bleeding and intracranial hemorrhage, complications of prematurity, and neurodevelopmental outcome at two years of age.
| Scheuermaier, Karine; Münch, Mirjam; Ronda, Joseph M et al. (2018) Improved cognitive morning performance in healthy older adults following blue-enriched light exposure on the previous evening. Behav Brain Res 348:267-275 |
| Bullock, B; Murray, G; Anderson, J L et al. (2017) Constraint is associated with earlier circadian phase and morningness: Confirmation of relationships between personality and circadian phase using a constant routine protocol. Pers Individ Dif 104:69-74 |
| Klerman, Elizabeth B; Wang, Wei; Phillips, Andrew J K et al. (2017) Statistics for Sleep and Biological Rhythms Research. J Biol Rhythms 32:18-25 |
| Rachmin, Inbal; O'Meara, Caitlin C; Ricci-Blair, Elisabeth M et al. (2017) Soluble interleukin-13r?1: a circulating regulator of glucose. Am J Physiol Endocrinol Metab 313:E663-E671 |
| Buxton, Orfeu M; Pavlova, Milena K; O'Connor, Shawn P et al. (2017) Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients. Nat Sci Sleep 9:187-198 |
| Juraschek, Stephen P; Miller 3rd, Edgar R; Weaver, Connie M et al. (2017) Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure. J Am Coll Cardiol 70:2841-2848 |
| Bray, G A; Ryan, D H; Johnson, W et al. (2017) Markers of dietary protein intake are associated with successful weight loss in the POUNDS Lost trial. Clin Obes 7:166-175 |
| Bianchi, Matt T; Phillips, Andrew J K; Wang, Wei et al. (2017) Statistics for Sleep and Biological Rhythms Research. J Biol Rhythms 32:7-17 |
| Swanson, C; Shea, S A; Wolfe, P et al. (2017) 24-hour profile of serum sclerostin and its association with bone biomarkers in men. Osteoporos Int 28:3205-3213 |
| Juraschek, Stephen P; Woodward, Mark; Sacks, Frank M et al. (2017) Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet. Hypertension 70:923-929 |
Showing the most recent 10 out of 721 publications
